Vivesto AB (OASMY) Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise Transcript

PresentationThe clock strikes 3:00 p.m., and we welcome viewers here to Vivesto's business update. Today, we will hear about the company with a focus towards the company's project portfolio, specifically Paccal Vet and Cantrixil in the midst of a capital raise. We will hear from internal speakers of the company as well as external speakers from both clinic and academia. And we will, of course, finish with a Q&A. [Operator Instructions]. But first and foremost, and without further ado, we now turn to Chairma ...